Water Island Capital’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-201,776
Closed -$807K 110
2025
Q2
$807K Buy
+201,776
New +$500K 0.12% 63

Water Island Capital's INZY Position: Q3 2025 in Review

Water Island Capital sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 201,776 shares — an estimated $807K sold.

Water Island Capital first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $807K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Water Island Capital reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Water Island Capital sold 201,776 Inozyme Pharma shares in Q3 2025, an estimated $807K.
  • Water Island Capital first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
  • Water Island Capital's Inozyme Pharma position peaked at $807K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Water Island Capital's 13F filing for Q3 2025, filed 14 Nov 2025.